Pfizer Q4 FY2021 Earnings Report Preview: What to Look For

0
153

Analysts estimate adjusted EPS of $0.85 vs. $0.42 in Q4 FY 2020. Pfizer’s revenue is expected to grow at a robust pace, but slower than Q3 FY 2021. The U.S. government has doubled its order for Pfizer’s recently approved oral treatment for COVID-19.

Source: Pfizer Q4 FY2021 Earnings Report Preview: What to Look For